891 related articles for article (PubMed ID: 12419479)
1. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
Kwiterovich PO
Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
[TBL] [Abstract][Full Text] [Related]
2. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
3. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
[TBL] [Abstract][Full Text] [Related]
4. [Disturbances of lipoprotein metabolism in metabolic syndrome].
Czyzewska M; Wolska A; Cwiklińska A; Kortas-Stempak B; Wróblewska M
Postepy Hig Med Dosw (Online); 2010 Jan; 64():1-10. PubMed ID: 20093718
[TBL] [Abstract][Full Text] [Related]
5. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
[TBL] [Abstract][Full Text] [Related]
6. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
[TBL] [Abstract][Full Text] [Related]
9. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
10. The small, dense LDL phenotype as a correlate of postprandial lipemia in men.
Lemieux I; Couillard C; Pascot A; Bergeron N; Prud'homme D; Bergeron J; Tremblay A; Bouchard C; Mauriège P; Després JP
Atherosclerosis; 2000 Dec; 153(2):423-32. PubMed ID: 11164432
[TBL] [Abstract][Full Text] [Related]
11. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
[TBL] [Abstract][Full Text] [Related]
12. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
13. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
14. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
Jansen H; Hop W; van Tol A; Bruschke AV; Birkenhäger JC
Atherosclerosis; 1994 May; 107(1):45-54. PubMed ID: 7945558
[TBL] [Abstract][Full Text] [Related]
16. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
[TBL] [Abstract][Full Text] [Related]
17. Dense low density lipoproteins and coronary artery disease.
Krauss RM
Am J Cardiol; 1995 Feb; 75(6):53B-57B. PubMed ID: 7863975
[TBL] [Abstract][Full Text] [Related]
18. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
20. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]